Axon Therapies
Axon Therapies is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
About Axon Therapies
Axon Therapies is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Axon Therapies develops a minimally invasive, implant-free catheter procedure called Splanchnic Ablation for Volume Management (SAVM) that targets the greater splanchnic nerve to reduce sympathetic nervous system activity and alleviate symptoms in patients with heart failure with preserved ejection fraction (HFpEF).
Explore Axon Therapies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.